Xanomeline reduced hallucinations in dementia trials before researchers developed it as a schizophrenia treatment.
Xanomeline reduced hallucinations in dementia trials before researchers developed it as a schizophrenia treatment.
More from this article
See all →Thalidomide destroys a cancer-causing protein through the same biological tagging process involved…
Moxidectin began as a veterinary dewormer before a nonprofit-funded trial found it cured 70% of…
In SURMOUNT-1, tirzepatide reduced prediabetes progression to type 2 diabetes by 94% over three…
Today’s longer-lasting GLP-1 drugs trace back to a peptide discovered in Gila monsters.
Exendin-4 lasts for hours, while natural human GLP-1 lasts minutes because one changed amino acid…
Gila monster venom contains Exendin-4, a peptide that resembles human GLP-1 and activates the same…
Most people begin regaining weight after stopping GLP-1 drugs, while an 18-month trial captures…
By June 2020, RECOVERY showed hydroxychloroquine failed while dexamethasone worked, months before…
Don't lose this one
A free account saves cards like this to your Collection, and Korva resurfaces them so you actually remember.